VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma. Cancer Discov. 2020 03; 10(3):440-459.
View in:
PubMed
subject areas
Animals
Antigen-Presenting Cells
Antineoplastic Combined Chemotherapy Protocols
B7-H1 Antigen
Cell Line, Tumor
Cell Proliferation
CREB-Binding Protein
Cyclin-Dependent Kinase Inhibitor p21
Genes, MHC Class I
Histocompatibility Antigens Class II
Histone Acetyltransferases
Histone Deacetylase Inhibitors
Histone Deacetylases
Humans
Immune System
Interferons
Lymphocytes, Tumor-Infiltrating
Lymphoma
Mice
Mutation
Proto-Oncogene Proteins c-bcl-6
Signal Transduction
authors with profiles
SATTVA S NEELAPU
CASSIAN YEE
LORETTA NASTOUPIL